BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 19264533)

  • 1. Biocatalysis in development of green pharmaceutical processes.
    Tao J; Xu JH
    Curr Opin Chem Biol; 2009 Feb; 13(1):43-50. PubMed ID: 19264533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New opportunities for biocatalysis: making pharmaceutical processes greener.
    Woodley JM
    Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocatalysis for pharmaceutical intermediates: the future is now.
    Pollard DJ; Woodley JM
    Trends Biotechnol; 2007 Feb; 25(2):66-73. PubMed ID: 17184862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocatalytic routes to chiral amines and amino acids.
    Gotor-Fernández V; Gotor V
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):784-97. PubMed ID: 19894190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroformylation and carbonylation processes: new trends in the synthesis of pharmaceuticals.
    Chaudhari RV
    Curr Opin Drug Discov Devel; 2008 Nov; 11(6):820-8. PubMed ID: 18946846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scalable enantioselective processes for chiral pharmaceutical intermediates.
    Iida T; Mase T
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):834-51. PubMed ID: 12478715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of biotransformations and biocatalysis to complexity generation in organic synthesis.
    Hudlicky T; Reed JW
    Chem Soc Rev; 2009 Nov; 38(11):3117-32. PubMed ID: 19847346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the development of new biocatalytic processes for practical pharmaceutical synthesis.
    Huisman GW; Collier SJ
    Curr Opin Chem Biol; 2013 Apr; 17(2):284-92. PubMed ID: 23462589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industrial biotransformations in the synthesis of building blocks leading to enantiopure drugs.
    Muñoz Solano D; Hoyos P; Hernáiz MJ; Alcántara AR; Sánchez-Montero JM
    Bioresour Technol; 2012 Jul; 115():196-207. PubMed ID: 22230779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Separation processes for organic molecules using SCF Technologies.
    Daintree LS; Kordikowski A; York P
    Adv Drug Deliv Rev; 2008 Feb; 60(3):351-72. PubMed ID: 18006179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.
    LaPorte TL; Wang C
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):738-45. PubMed ID: 17987525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active pharmaceutical ingredient (API) production involving continuous processes--a process system engineering (PSE)-assisted design framework.
    Cervera-Padrell AE; Skovby T; Kiil S; Gani R; Gernaey KV
    Eur J Pharm Biopharm; 2012 Oct; 82(2):437-56. PubMed ID: 22820647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applied biotransformations in green solvents.
    Hernáiz MJ; Alcántara AR; García JI; Sinisterra JV
    Chemistry; 2010 Aug; 16(31):9422-37. PubMed ID: 20669193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocatalytic synthesis of enantiopure building blocks for pharmaceuticals.
    Simon RC; Mutti FG; Kroutil W
    Drug Discov Today Technol; 2013; 10(1):e37-44. PubMed ID: 24050228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in industrial biocatalysis.
    Nestl BM; Nebel BA; Hauer B
    Curr Opin Chem Biol; 2011 Apr; 15(2):187-93. PubMed ID: 21195018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocatalysis for the production of carbohydrate esters.
    Chang SW; Shaw JF
    N Biotechnol; 2009 Oct; 26(3-4):109-16. PubMed ID: 19628056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of green chemistry in process research and development.
    Dunn PJ
    Chem Soc Rev; 2012 Feb; 41(4):1452-61. PubMed ID: 21562677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of incomplete removal of the tert-butoxycarbonyl protecting group during synthesis of a pharmaceutical drug substance on the residual solvent analysis.
    Beilin E; Baker LJ; Aikins J; Baryla NE
    J Pharm Biomed Anal; 2010 Jun; 52(2):316-9. PubMed ID: 20116957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective functionalization of small organic molecules using electrophilic nitrogen sources.
    Watson ID; Yudin AK
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):906-17. PubMed ID: 12478721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.